We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




CT and CT/PET Platforms Eliminate Tradeoffs Between Low Dose and Image Quality

By MedImaging International staff writers
Posted on 23 Dec 2010
Print article
A new computed tomography (CT) system features iDose4, a next-generation iterative reconstruction technique, designed to provide equivalent diagnostic image quality at up to 80% less dose; improve spatial resolution by up to 35% with up to 50% less dose; or simply improve spatial resolution by up to 68%. This new platform is available as a standalone or hybrid imaging system via the Ingenuity CT scanner and the Ingenuity TF positron emission tomography (PET)/CT system.

In November 2010 at the 96th annual meeting of the Radiological Society of North America (RSNA) in Chicago (IL, USA), Philips Healthcare (Best, The Netherlands) presented the new Philips Ingenuity CT platform. "The Ingenuity CT system maintains outstanding image quality at the absolute lowest possible dose without wasting a moment of valuable clinician time. In the past, because the combination of great image quality, low dose, and fast reconstruction times has been a challenge for the industry, CT scanning has often been about trade-offs. The launch of the Philips Ingenuity CT, the next step towards fully optimizing low-dose imaging, is proof of Philips' commitment to eliminating the need to make trade-offs in patient care,” said Gene Saragnese, general manager, imaging systems, for Philips Healthcare.

At the core of the Ingenuity CT is a new level of clinical integration and a wide variety of applications that put the focus on the patient while enhancing economic value. iDose4, Philips' newest generation iterative reconstruction technique adds improvement in image quality and fast reconstruction times, while reducing dose.

Another exclusive to the Ingenuity platform is SyncRight, a new tool designed to enhance communications between the scanner and the injector creating consistent image quality from patient to patient, up to 15% reduction in injected contrast per patient, providing better visualization of vascular structures, resulting in fewer repeat exams.

The Ingenuity CT platform provides the efficiency tools needed to help clinicians in the radiology, emergency, and /or pediatric department to remain competitive. Tools include RapidView IR and a new, easy to use operator console that was designed to increase throughput by up to 25% and reducing decision points by up to 50%.

The Ingenuity CT also integrates the IntelliSpace Portal and extended Brilliance Workspace, across hospital information systems (HIS), radiology information systems (RIS), and picture archiving and communication systems (PACS).

Ingenuity TF PET/CT is a new hybrid imaging system designed to conduct studies in oncology imaging, cardiac perfusion, and diagnostic CT. The system includes time-of-flight (TOF) technology for exceptional speed and full-fidelity PET imaging to enhance patient care.

Ingenuity TF PET/CT also improves imaging performance with the introduction of Astonish TF, the next evolution of TOF technology. Combined with four-dimensional (4D) TOF capabilities, Astonish TF shows a 50% improved contrast resolution while maintaining quantitative accuracy with up to four times the reconstruction speed of previous-generation systems. Moreover, the system also features iDose4 for an undivided and holistic approach to low-dose, high-quality CT imaging.

Related Links:
Philips Healthcare

Multi-Use Ultrasound Table
Clinton
X-ray Diagnostic System
FDX Visionary-A
Ultrasonic Pocket Doppler
SD1
Ultra-Flat DR Detector
meX+1717SCC

Print article

Channels

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.